# ACURA PHARMACEUTICALS, INC

ACURA PHARMACEUTICALS, INC is a company headquartered in Palatine, IL, United States.

## Company overview

- **Legal name:** ACURA PHARMACEUTICALS, INC
- **Former names in filing history:** HALSEY DRUG CO INC/NEW (1995-10-24 to 2004-08-16)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Palatine, IL, United States
- **Incorporated in:** NY
- **Fiscal year end:** December 31
- **SEC CIK:** 0000786947

## About

ACURA PHARMACEUTICALS, INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000786947, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-06-30, it reported annual revenue of USD 1,563,000; net income of USD -879,000; total assets of USD 860,000 for the fiscal period ended 2021-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2021 (period ended 2021-12-31)

- **Revenue:** $1.6M (USD 1,563,000)
- **Net income:** -$879,000 (USD -879,000)
- **Total assets:** $860,000 (USD 860,000)
- **Operating cash flow:** -$742,000 (USD -742,000)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $3.6M (USD 3,570,000)
- **Net income:** -$1.2M (USD -1,208,000)
- **Total assets:** $1.7M (USD 1,736,000)
- **Operating cash flow:** -$719,000 (USD -719,000)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2019 (period ended 2019-12-31)

- **Revenue:** $2.7M (USD 2,657,000)
- **Net income:** -$3.8M (USD -3,774,000)
- **Total assets:** $2.6M (USD 2,562,000)
- **Operating cash flow:** -$618,000 (USD -618,000)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2018 (period ended 2018-12-31)

- **Revenue:** $410,000 (USD 410,000)
- **Net income:** -$3.8M (USD -3,842,000)
- **Total assets:** $2.2M (USD 2,152,000)
- **Cash and equivalents:** $91,000 (USD 91,000)
- **Operating cash flow:** -$3.9M (USD -3,908,000)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2026-10-06 — period 2026-10-02 — FORM 8-K
- Form 8-K — filed 2026-08-20 — period 2026-08-14 — FORM 8-K
- Form 8-K — filed 2026-07-24 — period 2026-07-17 — FORM 8-K
- Form 8-K — filed 2026-06-29 — period 2026-06-29 — FORM 8-K
- Form 8-K — filed 2026-05-07 — period 2026-05-05 — FORM 8-K
- Form 8-K — filed 2026-03-10 — period 2026-03-09 — FORM 8-K
- Form 8-K — filed 2026-01-20 — period 2026-01-16 — FORM 8-K
- Form 8-K — filed 2025-12-29 — period 2025-12-23 — FORM 8-K
- Form 8-K — filed 2025-10-24 — period 2025-10-23 — FORM 8-K
- Form 8-K — filed 2025-09-04 — period 2025-09-03 — FORM 8-K
- Form 8-K — filed 2025-07-21 — period 2025-07-18 — FORM 8-K
- Form 8-K — filed 2025-06-24 — period 2025-06-20 — FORM 8-K

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/acura-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology